Member Login
  1. Stocks
    2. /
  2. AstraZeneca PLC (LSE: AZN)
    3. /

LSE:AZN (AstraZeneca PLC)

About AZN

AstraZeneca is a biopharmaceutical business that focuses on the discovery, development and commercialisation of prescription medicines, primarily for the treatment of diseases in three main therapy areas - Respiratory, Inflammation and Autoimmunity (RIA), Cardiovascular and Metabolic Disease (CVMD) and Oncology – as well as in Infection and Neuroscience.
Financial Market Data copyright © 2024 QuoteMedia. Data delayed 15 minutes unless otherwise indicated (view delay times for all exchanges). RT=Real-Time, EOD=End of Day, PD=Previous Day. Market Data powered by QuoteMedia. Terms of Use.

    • AstraZeneca PLC (LSE: AZN) Latest News

    Investing Videos

    Why Have GlaxoSmithKline plc And AstraZeneca plc Followed The FTSE 100 Down?

    | Owain Bennallack

    VIDEO: One Fool puts GlaxoSmithKline plc (LON:GSK) and AstraZeneca plc (LON:AZN) under the spotlight.

    Read more »

    Investing Articles

    Why Shire PLC, Hikma Pharmaceuticals Plc And BTG plc Could Complement AstraZeneca plc In Your Portfolio!

    | Peter Stephens

    Shire PLC (LON: SHP), Hikma Pharmaceuticals Plc (LON: HIK), BTG plc (LON: BTG) and AstraZeneca plc (LON: AZN) could have…

    Read more »

    Investing Articles

    How Much Lower Can Shire PLC Go?

    | Rupert Hargreaves

    Shire PLC (LON: SHP) and AstraZeneca plc (LON:AZN) could fall further now mergers are off the table.

    Read more »

    Investing Articles

    Why Smith & Nephew plc’s Latest Failure Should Worry AstraZeneca plc And GlaxoSmithKline plc

    | Royston Wild

    Royston Wild explains how Smith and Nephew plc (LON: SN)'s latest testing woes underlines the precarious nature of drugs testing

    Read more »

    Investing Articles

    Why I’d Still Buy AstraZeneca plc Despite Shire PLC Deal Collapse

    | Peter Stephens

    AstraZeneca plc (LON: AZN) still looks hugely attractive – even after the collapse of AbbVie’s Shire PLC (LON: SHP) takeover

    Read more »

    Investing Articles

    What Happens If Pfizer Inc. Doesn’t Come Back For AstraZeneca plc?

    | Rupert Hargreaves

    AstraZeneca plc (LON: AZN) could fall if Pfizer doesn't return -- GlaxoSmithKline plc (LON: GSK) is a better choice, this…

    Read more »

    Investing Articles

    GlaxoSmithKline PLC vs AstraZeneca PLC: Which Is The Better Dividend Play?

    | Prabhat Sakya

    Is GlaxoSmithKline plc (LON:GSK) or AstraZeneca plc (LON: AZN) the better high-yield play?

    Read more »

    Investing Articles

    Will AstraZeneca plc Take The Hatchet To Its Dividend?

    | Royston Wild

    Royston Wild explains why AstraZeneca plc (LON: AZN) may have to slash shareholder payments.

    Read more »

    Investing Articles

    Is AstraZeneca plc A Promising Capital-Growth Investment?

    | Kevin Godbold

    Some firms' growth is more sustainable than others. What about AstraZeneca plc (LON: AZN)?

    Read more »

    Investing Articles

    3 Stocks To Beat The FTSE 100: Unilever plc, AstraZeneca plc And British American Tobacco plc

    | Peter Stephens

    These 3 shares could outperform the wider index: Unilever plc (LON: ULVR), AstraZeneca plc (LON: AZN) and British American Tobacco…

    Read more »

    Investing Articles

    3 Stocks To Avoid In A Plunging Market: AstraZeneca plc, Centrica PLC & Thomas Cook Group plc

    | Alessandro Pasetti

    Tough times ahead for AstraZeneca plc (LON:AZN) Centrica PLC (LON:CNA), and Thomas Cook Group plc (LON:TCG) if the stock market…

    Read more »

    Investing Articles

    Is Now The Right Time To Buy AstraZeneca plc?

    | Roland Head

    AstraZeneca plc (LON:AZN) shares reflect lingering hopes of another bid.

    Read more »